Synonym: (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione; 4-Demethoxydaunorubicin hydrochloride; DMDR; IMI-30; Idamycin
CAS Number: 57852-57-0
Empirical Formula (Hill Notation): C26H27NO9 · HCl
Molecular Weight: 533.95
EC Number: 260-990-7
MDL Number: MFCD00866457
Linear Formula: C26H27NO9 · HCl
Product Type: Chemical
This image is provided for informative purposes only and does not represent an actual product label. It should not be used as a substitute for official product labeling.
| form |
solid |
| InChI |
1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1 |
| InChI key |
XDXDZDZNSLXDNA-TZNDIEGXSA-N |
| originator |
Johnson & Johnson |
| Quality Level |
200  |
| shipped in |
wet ice |
| SMILES string |
[H][C@@]1(C[C@@](O)(Cc2c(O)c3C(=O)c4ccccc4C(=O)c3c(O)c12)C(C)=O)O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5 |
| storage temp. |
2-8°C |
| Application: |
Idarubicin is an anthracycline antibiotic that is an anti-leukemia agent with higher DNA binding capacity and greater cytotoxicity than daunorubicin. |
| Biochem/physiol Actions: |
Topoisomerase II inhibitor |
| Features and Benefits: |
This compound is a featured product for Apoptosis research. Click here to discover more featured Apoptosis products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: |
This compound was developed by Johnson & Johnson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: |
10 mg in glass bottle |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |